New market study, "Analgesics in Saudi Arabia", has been published

The strong performance of analgesics in 2015 was driven mainly by the rising consumer preference for widely advertised international brands, which are usually considered to be of higher quality and which offer fast-acting relief from pain and fever, despite the slightly higher cost of these products in comparison with domestic brands. Another positive factor is the expansion of retail distribution channels in analgesics to include supermarkets, hypermarkets and convenience stores, channels which offer added convenience, especially for consumers with limited mobility, which in Saudi Arabia includes women, all of whom are forbidden from driving.

Competitive Landscape

GlaxoSmithKline Plc continued to lead analgesics in 2015 with a 26% value share. The company has been able to maintain its leading position due to new product innovations such as the launch of Panadol Advance in acetaminophen in 2014. This new addition to the Panadol range is marketed as being both faster acting and gentler than rival products. In addition, the company also recently introduced Panadol Cold & Flu Hot Lemon & Honey, a powdered medication packaged in a sachet to be mixed with hot water. These new product innovations have proven quite to be quite beneficial for the company in terms of improving the company’s ability to target new consumer bases. In addition, GlaxoSmithKline enjoys strong brand awareness, primarily due to its highly detailed marketing strategies and increased spending on advertising.

Full Report Details at
- http://www.fastmr.com/prod/1112995_analgesics_saudi_arabia.aspx?afid=301

Industry Prospects

Analgesics in Saudi Arabia is expected to continue registering a strong performance over the forecast period, increasing in value at a CAGR of 6% at constant 2015 prices, a superior rate of growth to the 4% value CAGR recorded in constant 2015 terms over the review period. This acceleration in growth is set to be to the general lack of regulations prohibiting pharmacists from selling prescription medicines UTC to customers without a prescription. Growth in the category is also set to continue being driven by advertising campaigns for OTC analgesics on satellite television, online and in the print media.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Saudi Arabia with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Saudi Arabia, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Saudi Arabia market research report includes:

* Analysis of key supply-side and demand trends

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Analgesics in Japan
- Analgesics in Denmark
- Analgesics in the United Kingdom
- Analgesics in Russia
- Analgesics in Sweden